TY - JOUR
T1 - Subretinal pseudocyst
T2 - A novel optical coherence tomography finding in age-related macular degeneration
AU - Sacconi, Riccardo
AU - Mullins, Robert F.
AU - Lutty, Gerard A.
AU - Borrelli, Enrico
AU - Bandello, Francesco
AU - Querques, Giuseppe
N1 - Publisher Copyright:
© The Author(s) 2019.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Purpose: To report the presence of a new structural optical coherence tomography finding, namely, subretinal pseudocysts, in a patient affected by age-related macular degeneration. Methods: Case report including multimodal imaging discussion. Case Report: We report a case of a 77-year-old woman affected by age-related macular degeneration from 7 years. Best corrected visual acuity was counting fingers and 20/40 in the right and left eye, respectively. The left eye was affected by type 1 macular neovascularization treated by 34 intravitreal injections of anti-vascular endothelial growth factor (22 ranibizumab and 12 aflibercept injections). Interestingly, structural optical coherence tomography showed the persistence of a subretinal cystoid space (i.e. ‘subretinal pseudocyst’) after the last anti-vascular endothelial growth factor treatment, even in absence of other signs of exudation. Conclusions: Subretinal pseudocysts are a new structural optical coherence tomography entity. We reported for the first time the evidence that pseudocysts may develop in the subretinal space in a case of age-related macular degeneration.
AB - Purpose: To report the presence of a new structural optical coherence tomography finding, namely, subretinal pseudocysts, in a patient affected by age-related macular degeneration. Methods: Case report including multimodal imaging discussion. Case Report: We report a case of a 77-year-old woman affected by age-related macular degeneration from 7 years. Best corrected visual acuity was counting fingers and 20/40 in the right and left eye, respectively. The left eye was affected by type 1 macular neovascularization treated by 34 intravitreal injections of anti-vascular endothelial growth factor (22 ranibizumab and 12 aflibercept injections). Interestingly, structural optical coherence tomography showed the persistence of a subretinal cystoid space (i.e. ‘subretinal pseudocyst’) after the last anti-vascular endothelial growth factor treatment, even in absence of other signs of exudation. Conclusions: Subretinal pseudocysts are a new structural optical coherence tomography entity. We reported for the first time the evidence that pseudocysts may develop in the subretinal space in a case of age-related macular degeneration.
KW - Age-related macular degeneration
KW - cystoid macular edema
KW - optical coherence tomography
KW - optical coherence tomography angiography
KW - subretinal pseudocyst
UR - http://www.scopus.com/inward/record.url?scp=85064955102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064955102&partnerID=8YFLogxK
U2 - 10.1177/1120672119846437
DO - 10.1177/1120672119846437
M3 - Article
C2 - 31018677
AN - SCOPUS:85064955102
SN - 1120-6721
VL - 30
SP - NP24-NP26
JO - European journal of ophthalmology
JF - European journal of ophthalmology
IS - 3
ER -